focus -WSS

focus

author：focus 2025-09-30 00:47:34 - browse：76548

Adobe

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued the company at about $1 billion. But despite several strategic pivots, including shifting to direct-to-consumer sales, the company failed to build a sustainable business model. Akili in April announced it would wind down its existing commercial operations and focus on a licensing deal with Japanese pharma company Shionogi while it figured out the best path forward.

Akili is just one of many health tech companies that are struggling following an explosion of investor interest in digital health during the Covid-19 pandemic. In the last month alone, Better Therapeutics, another company making digital treatments, sold its assets for an undisclosed amount after failing to build a business around its app for type 2 diabetes, and Cue Health, a diagnostics startup, shut down after funding interest in its Covid-19 tests evaporated.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Eli Lilly’s Mounjaro succeeds in second weight

focus

WSS

The thinking behind the controversial eating disorder chatbot Tessa

Timeline: Key moments in fight for gay rights

Can medical device makers keep up in the race to treat obesity?

Physician executives need more than on

Inside the rise of 'mukbang' eating videos

Analysis of telehealth claims data suggest service duplication

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

Hollywood unions extend contract negotiations for actors

A virus, fished out of a lake, may have saved a man’s life

Walensky prepares to leave CDC — and Congress — behind

Novo: Oral version of Ozempic leads to 15% weight loss

At least 13 dead in Texas as scorching temps continue

Reanimated hearts work just as well for transplants, study finds

Tori Bowie and the unacceptable rates of Black maternal death

AI can decode, harness the power of the humane immune system

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Sana to lay off nearly a third of staff, de

hotspot

The future of health care in the House

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Physician executives need more than on

Analysis of telehealth claims data suggest service duplication

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

explore

focus

entertainment

Wikipedia